Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan · Delayed Price · Currency is TWD 17.00
+0.20 (1.19%)
Aug 19, 2026, 9:38 AM CST
Welgene Biotech Market Cap
Welgene Biotech has a market cap or net worth of 391.51 million as of August 18, 2026. Its market cap has decreased by -16.21% in one year.
Market Cap
391.51M
Enterprise Value
444.57M
Revenue
398.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.00
ChartMarket Cap Chart
Since October 23, 2017, Welgene Biotech's market cap has decreased from 575.10M to 391.51M, a decrease of -31.92%. That is a compound annual growth rate of -4.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 391.51M | -9.68% |
| Dec 31, 2025 | 433.46M | -21.85% |
| Dec 30, 2024 | 554.64M | 6.49% |
| Dec 29, 2023 | 520.85M | 0.68% |
| Dec 30, 2022 | 517.35M | -9.20% |
| Dec 30, 2021 | 569.79M | -23.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 3.09B |
| DIVA Laboratories | 1.94B |
| Puriblood Medical | 1.11B |
| Genetics Generation Advancement | 1.07B |
| Kim Forest Enterprise | 803.11M |
| Sofiva Genomics | 726.62M |
| TFBS Bioscience | 686.55M |
| Pharmigene | 371.42M |